历史超声波系统的无侵入性超声波系统 提前获得英国批准 治疗肝肿瘤 HistoSonics' non-invasive ultrasound system gains early UK approval for treating liver tumors.

希斯托索尼克公司的爱迪生囊系统已在英国获得早期市场准入,用于治疗肝脏瘤. HistoSonics' Edison Histotripsy System has been granted early market access in the UK for treating liver tumors. 该系统对液化肿瘤使用非侵入焦点超声波超声波,无需手术或辐射。 The system uses non-invasive focused ultrasound to liquefy tumors without surgery or radiation. 这项技术是英国创新设备获取途径的首款, 已经在美国获得FDA批准. Approved through the UK's Innovative Devices Access Pathway, the technology is the first of its kind and has already received FDA clearance in the U.S. HistoSonics is now seeking broader European approval.